SCHEMBL2176759

SCHEMBL2176759

NC(=O)[C@@H](N)c1ccncn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.42
HSP90AA1 P07900 1/20 0.39
CYP19A1 P11511 1/20 0.35
MKNK1 Q9BUB5 1/20 0.34
HPGDS O60760 1/20 0.32
GRM4 Q14833 1/20 0.32
SIRT3 Q9NTG7 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
AKT1 P31749 1/20 0.32
KDM4E B2RXH2 2/20 0.31
ADORA3 P0DMS8 2/20 0.31
CYP1A2 P05177 2/20 0.31
CYP3A4 P08684 2/20 0.31
CTNNB1 P35222 1/20 0.31
WNT3A P56704 1/20 0.31
MPO P05164 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2A6 P11509 1/20 0.31
CYP2C19 P33261 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2176754 1.00 P2RX7 (0.42) P2RX7HSP90AA1CYP19A1MKNK1HPGDS
SCHEMBL14968784 0.82 P2RX7 (0.43) P2RX7HSP90AA1CYP19A1MKNK1HPGDS
SCHEMBL5390729 0.76 KMT2A (0.40) P2RX7TDP1KDM4ETSHR
SCHEMBL20993622 0.74 CYP1A2 (0.45) KDM4ECYP1A2CYP3A4CYP2C19TSHR
SCHEMBL1534974 0.74 CYP1A2 (0.45) KDM4ECYP1A2CYP3A4CYP2C19TSHR
SCHEMBL20993625 0.74 CYP1A2 (0.45) KDM4ECYP1A2CYP3A4CYP2C19TSHR
SCHEMBL4557709 0.74 ALDH1A1 (0.44) P2RX7CYP19A1TDP1KDM4ECYP1A2
SCHEMBL28300910 0.74 P2RX7 (0.40) P2RX7HSP90AA1CYP19A1MKNK1KDM4E
SCHEMBL16150460 0.73 P2RX7 (0.42) P2RX7HSP90AA1CYP19A1AKT1KDM4E
SCHEMBL28864538 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds DPYD, TP53, TYMP P2RX7 469/4885HSP90AA1 3381/4885CYP19A1 1636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.